Skip to main content

Market Overview

Polyrizon Stock Slides After Hours After 52% Surge On Tuesday: Why It Moved

Share:
Polyrizon Stock Slides After Hours After 52% Surge On Tuesday: Why It Moved

Polyrizon Ltd (NASDAQ:PLRZ) saw a dip in its stock value during after-hours trading on Wednesday.

What Happened: The after-hours price of Polyrizon’s stock was $0.92, marking a 12.02% dip from the previous day’s closing price of $1.04. This follows a regular trading session surge of 52.47%.

See Also: Virginia Homeowner Says Neighbor Illegally Cut Down 89-Year-Old Oak Tree On His Land — Then Had the Nerve To ‘Demand’ He Pay Half The $2k Bill – Benzinga

The surge in the stock value on Tuesday follows the company’s successful appeal to the NASDAQ panel, which enabled it to retain its listing on the exchange. The appeal was crucial for the biotech company, as it faced the risk of being delisted due to non-compliance with Nasdaq’s listing rules.

Why It Matters: Polyrizon’s stock value has been on a rollercoaster ride recently. Earlier in July, the company’s stock value also experienced a significant increase after the news of its continued Nasdaq listing. This was after a hearing panel confirmed the company’s compliance with the exchange’s listing rules.

These developments come on the heels of Polyrizon’s announcement of successful preclinical results from a study evaluating its Trap & Target platform. The study showed that the platform’s formulation achieved targeted deposition in the upper regions of the nasal cavity.

Price Action: PLRZ surged 52.47% to close at $1.04 on July 16, according to Benzinga Pro data.

Benzinga’s Edge Stock Rankings indicate Polyrizon stocks have negative trends across all time frames. Know how the stock fares on other parameters here.

Read Next:

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Photo Courtesy: Shutterstock/iQoncept

 

Related Articles (PLRZ)

View Comments and Join the Discussion!

Posted-In: Biotech Equities News Events Market-Moving Exclusives Signals Pre-Market Outlook Markets

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com